Hims & Hers Health Shares Outstanding 2020-2026 | HIMS
Hims & Hers Health shares outstanding history from 2020 to 2026. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- Hims & Hers Health shares outstanding for the quarter ending June 30, 2026 were 0.232B, a 9.75% decline year-over-year.
- Hims & Hers Health 2025 shares outstanding were 0.258B, a 9.05% increase from 2024.
- Hims & Hers Health 2024 shares outstanding were 0.237B, a 13.12% increase from 2023.
- Hims & Hers Health 2023 shares outstanding were 0.209B, a 2.36% increase from 2022.
|
Hims & Hers Health Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025 | 258 |
| 2024 | 237 |
| 2023 | 209 |
| 2022 | 205 |
| 2021 | 187 |
| 2020 | 35 |
| 2019 | 35 |
|
Hims & Hers Health Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2026-06-30 | 232 |
| 2026-03-31 | 228 |
| 2025-12-31 | 258 |
| 2025-09-30 | 249 |
| 2025-06-30 | 257 |
| 2025-03-31 | 247 |
| 2024-12-31 | 237 |
| 2024-09-30 | 235 |
| 2024-06-30 | 235 |
| 2024-03-31 | 229 |
| 2023-12-31 | 209 |
| 2023-09-30 | 210 |
| 2023-06-30 | 208 |
| 2023-03-31 | 207 |
| 2022-12-31 | 205 |
| 2022-09-30 | 205 |
| 2022-06-30 | 204 |
| 2022-03-31 | 203 |
| 2021-12-31 | 187 |
| 2021-09-30 | 200 |
| 2021-06-30 | 192 |
| 2021-03-31 | 153 |
| 2020-12-31 | 35 |
| 2020-09-30 | 36 |
| 2020-06-30 | 35 |
| 2020-03-31 | 35 |
| 2019-09-30 | 5 |
| 2019-06-30 | 5 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $6.498B | $2.348B |
| Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $43.168B | 43.07 |
| Tempus AI (TEM) | United States | $12.423B | 0.00 |
| 10x Genomics (TXG) | United States | $9.692B | 0.00 |
| Hinge Health (HNGE) | United States | $7.455B | 71.62 |
| Doximity (DOCS) | United States | $4.601B | 28.36 |
| Heartflow (HTFL) | United States | $4.202B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $3.688B | 243.22 |
| Privia Health (PRVA) | United States | $2.601B | 96.95 |
| Clover Health Investments (CLOV) | United States | $2.475B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.157B | 32.86 |
| Butterfly Network (BFLY) | United States | $2.077B | 0.00 |
| Schrodinger (SDGR) | United States | $1.716B | 0.00 |
| Omnicell (OMCL) | United States | $1.484B | 21.19 |
| Azenta (AZTA) | United States | $1.447B | 78.64 |
| Enovis (ENOV) | United States | $1.035B | 5.36 |
| Talkspace (TALK) | United States | $0.879B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.668B | 0.00 |
| Phreesia (PHR) | United States | $0.642B | 34.50 |
| Claritev (CTEV) | United States | $0.602B | 0.00 |
| Veradigm (MDRX) | United States | $0.594B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.586B | 0.00 |
| Evolent Health (EVH) | United States | $0.423B | 0.00 |
| Carlsmed (CARL) | United States | $0.416B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.371B | 0.00 |
| CapsoVision (CV) | United States | $0.319B | 0.00 |
| Standard BioTools (LAB) | United States | $0.271B | 0.00 |
| American Well (AMWL) | United States | $0.226B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.145B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.132B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.129B | 0.00 |
| CareCloud (CCLD) | United States | $0.087B | 6.41 |
| Pulmonx (LUNG) | United States | $0.082B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.064B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.060B | 0.00 |
| Outset Medical (OM) | United States | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.058B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.051B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.033B | 0.00 |
| 111 (YI) | China | $0.031B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.025B | 0.00 |
| HeartBeam (BEAT) | United States | $0.024B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| HeartSciences (HSCS) | United States | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| DataMeds AI (MEDS) | United States | $0.005B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.001B | 0.00 |
| TruBridge (TBRG) | United States | $0.000B | 0.00 |